National Cancer Institute; Notice of Meeting, 46092 [07-4016]
Download as PDF
<![CDATA[
46092
Federal Register / Vol. 72, No. 158 / Thursday, August 16, 2007 / Notices
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: August 9, 2007.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E7–16169 Filed 8–15–07; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Processing Methods for Orthopedic,
Cardiovascular, and Skin Allografts;
Public Workshop
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of public workshop.
The Food and Drug Administration
(FDA), Center for Biologics Evaluation
and Research (CBER), Center for Devices
and Radiological Health (CDRH), and
Office of Regulatory Affairs (ORA) and
the Centers for Disease Control and
Prevention (CDC) are announcing a
public workshop entitled ‘‘Processing
Methods for Orthopedic,
Cardiovascular, and Skin Allografts.’’
The purpose of the public workshop is
to discuss various methods used to
process tissue allograft, pre- and postprocessing cultures, and disinfection
and sterilization of tissues.
Date and Time: The public workshop
will be held on October 11, 2007, from
8:30 a.m. to 5 p.m., and October 12,
2007, from 8:30 a.m. to 1 p.m.
Location: The public workshop will
be held at the Masur Auditorium,
Building 10 Clinical Center, National
Institutes of Health, Bethesda, MD
20892.
rwilkins on PROD1PC63 with NOTICES
Contact: Bernadette Kawaley, Center
for Biologics Evaluation and Research
(HFM–43), Food and Drug
Administration, 1401 Rockville Pike,
suite 200N, Rockville, MD 20852–1448,
301–827–2000, FAX: 301–827–3079, email:
CBERTrainingSuggestions@fda.hhs.gov
(Subject line: Tissue Processing
Workshop).
Registration: Mail or fax your
registration information (including
name, title, firm name, address,
telephone and fax numbers) to the
contact person by September 18, 2007.
There is no registration fee for the
public workshop. Early registration is
recommended because seating is
limited. Registration on the day of the
VerDate Aug<31>2005
17:27 Aug 15, 2007
Jkt 211001
public workshop will be provided on a
space available basis beginning at 8 a.m.
If you need special accommodations
due to a disability, please contact
Bernadette Kawaley (see Contact) at
least 7 days in advance.
SUPPLEMENTARY INFORMATION: The
public workshop will feature
presentations by experts from the
government, the medical field and the
tissue industry. The first day of the
workshop will include discussions on:
(1) Surgeon clinical practices,
experiences, expectations, and
assumptions regarding tissue allografts
and patient safety; and (2) Pre- and PostProcessing cultures for
microorganisms—usefulness, reliability,
and validation. The second day of the
workshop will focus on disinfection and
sterilization of tissues—experiences,
expectations, and challenges.
Transcripts: Transcripts of the public
workshop may be requested in writing
from the Freedom of Information Office
(HFI–35), Food and Drug
Administration, 5600 Fishers Lane, rm.
6–30, Rockville, MD 20857,
approximately 15 working days after the
public workshop at a cost of 10 cents
per page. A transcript of the public
workshop will be available on the
Internet at https://www.fda.gov/cber/
minutes/workshop-min.htm.
Dated: August 10, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7–16182 Filed 8–15–07; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.c. Appendix 2), notice
is hereby given of a meeting of the
National Cancer Institute Director’s
Consumer Liaison Group.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Director’s Consumer Liaison Group.
Date: October 24–25, 2007.
Time: 8:30 a.m. to 3:30 p.m.
Agenda: 1. Approval of Minutes; 2. Reports
from Dr. John E. Niederhuber, NCI Director;
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
3. Reports on NCI Budget; Legislative
Activity; NCI Scientific Initiatives reported
by NCI staff; 4. Presentations on Eliminating
Cancer Health Disparities; Translational
Working Group; and the Adolescent and
Young Adult Oncology (AYAO) Progress
Review Group (PRG) 5. Public Comment; 6.
Action Items and Conclusion.
Place: National Institutes of Health,
Building 31, 9000 Rockville Pike, C Wing,
6th Floor, Conference Rm. 6, Bethesda, MD
20892.
Contact Person: Barbara Guest, Executive
Secretary, Office of Liaison Activities,
National Cancer Institute, National Institutes
of Health, 6116 Executive Blvd, Room 2202,
Bethesda, MD 20892–8324, Bethesda, MD
20892–8324, 301–496–0307,
guestb@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show on
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/dclg/dclg.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of health,
HHS)
Dated: August 9, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–4016 Filed 8–15–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary
and Alternative Medicine; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
E:\FR\FM\16AUN1.SGM
16AUN1
]]>Agencies
[Federal Register Volume 72, Number 158 (Thursday, August 16, 2007)]
[Notices]
[Page 46092]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-4016]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.c. Appendix 2), notice is hereby given of a meeting of
the National Cancer Institute Director's Consumer Liaison Group.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: National Cancer Institute Director's Consumer
Liaison Group.
Date: October 24-25, 2007.
Time: 8:30 a.m. to 3:30 p.m.
Agenda: 1. Approval of Minutes; 2. Reports from Dr. John E.
Niederhuber, NCI Director; 3. Reports on NCI Budget; Legislative
Activity; NCI Scientific Initiatives reported by NCI staff; 4.
Presentations on Eliminating Cancer Health Disparities;
Translational Working Group; and the Adolescent and Young Adult
Oncology (AYAO) Progress Review Group (PRG) 5. Public Comment; 6.
Action Items and Conclusion.
Place: National Institutes of Health, Building 31, 9000
Rockville Pike, C Wing, 6th Floor, Conference Rm. 6, Bethesda, MD
20892.
Contact Person: Barbara Guest, Executive Secretary, Office of
Liaison Activities, National Cancer Institute, National Institutes
of Health, 6116 Executive Blvd, Room 2202, Bethesda, MD 20892-8324,
Bethesda, MD 20892-8324, 301-496-0307, guestb@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show on
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: deainfo.nci.nih.gov/advisory/dclg/dclg.htm, where an agenda
and any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of health, HHS)
Dated: August 9, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-4016 Filed 8-15-07; 8:45 am]
BILLING CODE 4140-01-M
